Method of Screening Baff Suppressor or Inhibitor
AssigneeKowa Company, Ltd.
InventorsTsutomu Takeuchi, Kensei Tsuzaka, Keiko Yoshimoto
Life of this patent
Estimating the term…
Loading patent…
AssigneeKowa Company, Ltd.
InventorsTsutomu Takeuchi, Kensei Tsuzaka, Keiko Yoshimoto
Estimating the term…
A method of screening a novel BAFF suppressor or inhibitor. More specifically speaking, a method which comprises adding a combination of TPA with ionomycin and/or an anti-CD3 antibody to a cultured human cell to thereby induce the production of BAFF by the cell; a method of screening a substance capable of suppressing the expression or activity of BAFF which comprises adding a test substance to a BAFF-production system prepared by adding a combination of TPA with ionomycin and/or an anti-CD3 antibody to a cultured human cell and measuring the expression amount and/or the activity of BAFF in the BAFF-production system; and a BAFF production inducer for a BAFF-producing cell which contains a combination of TPA with ionomycin and/or an anti-CD3 antibody.
A method of inducing the production of BAFF in a cultured human T cell, which comprises adding a combination of TPA with ionomycin and/or an anti-CD antibody to the cell.
A method of screening a substance capable of regulating the expression or activity of BAFF, which comprises adding a test substance to a BAFF production system in which a combination of TPA with ionomycin and/or an anti-CD3 antibody are/is added to a cultured human T cell and then measuring the expression level and/or activity level of BAFF in the BAFF production system.
A method of screening a prophylactic/therapeutic agent for autoimmune diseases such as systemic lupus erythematosus (SLE), chronic rheumatoid arthritis (RA), Sjogren's syndrome (SS), autoimmune diabetes, AIDS, and an autoimmune disease accompanied by B-cell activation, which comprises adding a test substance to a BAFF production system in which a combination of TPA with ionomycin and/or an anti-CD3 antibody are/is added to a cultured human T cell and then measuring the expression level and/or activity of BAFF in the BAFF production system.
A BAFF production inducer for a BAFF-producing cell, which contains a combination of TPA with ionomycin and/or an anti-CD3 antibody.
Dependencies are inferred from the claim text.